Clinical Trial Update: Carfilzomib, Cyclophosphamide, Dexamethasone in Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating carfilzomib, cyclophosphamide, and dexamethasone in multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Carfilzomib (carfilzomib)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Multiple Myeloma | Phase 2 | Status: UNKNOWN